Blood Cancer United Inc
Blood Cancer United Inc, based in Washington, DC, is a public charity that funds blood cancer research and provides patient and family support and advocacy. The organization was formerly known as the Leukemia & Lymphoma Society; its website describes Blood Cancer United as an evolution of that organization, with the mission of curing blood cancer and improving quality of life.
Blood Cancer United Inc at a glance
In short: Blood Cancer United Inc gave $47.7M across 67 grants in 2025 (avg $713K), top state Massachusetts. 10% of 2025 grantees were new. Source: 2025 IRS Form 990.
- Annual giving (2025)
- $47,747,287
- -8.6% vs 2024
- Grants made (2025)
- 67
- -2.9% vs 2024
- Average grant
- $712,646
- -5.9% vs 2024
- Median grant
- $370,000
- Total assets
- $532,209,663
- -11.6% vs 2024
- New grantees (estimate)
- 10% first-time grantees (7 of 67, 2025)
- Primary geography
- Massachusetts (17% of itemized 2025 grant dollars)
- Latest 990 filing
- Form 990, 2025 View filing
Data from IRS Form 990, 2025; updated October 2026. New grantees are estimated by matching recipient names across years (methodology).
How to apply to Blood Cancer United Inc
- Review Cycle
- The eligibility-phase deadline listed for the Career Development Program Scholar and Scholar in Clinical Research awards was October 17, 2025, which has passed.
- Deadline
- The eligibility-phase deadline listed for the Career Development Program Scholar and Scholar in Clinical Research…
- Contact
Mailing address: 1201 15Th Street Nw Suite 410, Washington, DC 20005
Phone: (914) 949-5213
Website: https://bloodcancerunited.org
Application details from Grantable's research on the foundation's public materials; confirm on its website before applying.
Open Grants
6 open opportunities from Blood Cancer United Inc
Career Development Program: Fellow Award Grant
Blood Cancer United Inc
Amount
US $65,000 - US $70,000
Deadline
Deadline not published
Career Development Program: Scholar Grant
Blood Cancer United Inc
Amount
Up to US $120,000
Deadline
Deadline not published
Career Development Program: Scholar in Clinical Research Grant
Blood Cancer United Inc
Amount
Up to US $125,000
Deadline
Deadline not published
Who Blood Cancer United Inc funds
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2025
The largest 2025 recipient was Dana-Farber Cancer Institute Inc ($5.2M). Together the top 10 received $24.0M.
Grant Size Distribution
358 grants across all recorded years
The most common grant size was in the $100–250K range: 101 grants of 358 (28%).
Geographic Focus
Where this funder awards grants
The 2025 grant dollars were distributed across recipient states, led by Massachusetts (17%), New York (16%), California (9%), Texas (9%), and Georgia (9%). The organization’s filing narrative says its research funding supported work in the United States, Canada, and nine other countries in fiscal year 2024. Its website describes its research as taking place around the world.
Grant Distribution by State
Share of 2025 grant dollars across all 67 itemized grants.
States
Cities
Is Blood Cancer United Inc open to new grantees?
10%
first-time grantees, 2025
In 2025, 7 of 67 grantees (10%) were first-time recipients. First grants averaged $461K; repeat grants $742K. How we count
Medians: $500K first-time, $370K repeat.
- 85% of 2025 grantees were also funded in 2024. Method
- Giving held roughly steady from 2022 to 2025 (+12%). Method
Estimate from itemized grant lists in IRS Form 990 filings (2019–2025). Recipient names are matched across years, so a renamed or misspelled grantee can look new; grants to individuals are left out. Methodology.
Giving History
Giving Over Time
Total grant dollars and number of grants per year
From 2019 to 2025, annual grant giving ranged from $26.4M (2020) to $52.3M (2024). In 2025 it made 67 grants totaling $47.7M.
Grants by year
Grant recipients and amounts by year
| Recipient | Purpose | Amount |
|---|---|---|
| Dana-Farber Cancer Institute Inc Boston, MA | Research Grant | $5,197,687 |
| The University of Texas MD Anderson Cancer Center Houston, TX | Research Grant | $2,518,448 |
| Sloan Kettering Institute for Cancer Research New York, NY | Research Grant | $2,513,800 |
| The Board of Trustees of the Leland Stanford Junior University Stanford, CA | Research Grant | $2,257,440 |
| Washington University in St Louis St. Louis, MO | Research Grant | $2,252,023 |
| Joan & Sanford I Weill Medical College of Cornell University New York, NY | Research Grant | $2,115,000 |
| University of Florida Gainesville, FL | Research Grant | $2,009,874 |
| University of Colorado Denver Anschutz Medical Campus Aurora, CO | Research Grant | $1,966,500 |
| Emory University Atlanta, GA | Research Grant | $1,661,071 |
| Fred Hutchinson Cancer Center Seattle, WA | Research Grant | $1,550,000 |
Ready to take the next step with Blood Cancer United Inc?
Financial History
Multi-year comparison from IRS filings
| Filing year | Total Assets | Revenue | Expenses | Grants paid | Grants | Net Investment Income |
|---|---|---|---|---|---|---|
| 2025 | $532,209,663 | $358,698,504 | $398,128,476 | $47,747,287 | 67 | $22,273,771 |
| 2024 | $602,010,519 | $368,242,059 | $371,792,172 | $52,250,782 | 69 | $16,623,882 |
| 2023 | $643,891,871 | $378,338,490 | $386,072,968 | $48,290,730 | 76 | $15,134,480 |
| 2022 | $693,676,206 | $426,997,204 | $518,622,394 | $42,492,815 | 74 | $6,919,696 |
| 2021 | $743,613,782 | $477,663,716 | $359,848,179 | $31,128,791 | 72 | $12,298,324 |
| 2020 | $581,677,610 | $496,221,309 | $393,996,450 | $26,353,311 | 74 | $33,847,009 |
| 2019 | $454,102,204 | $396,221,152 | $367,321,473 | $41,241,114 | 84 | $8,619,914 |
Research compiled by Grantable AI from public sources. Last updated October 2026.
Mission & Focus Areas
The organization’s mission is to cure blood cancer and improve the quality of life of patients and their families. Its research funding spans discovery science, translational and clinical research, and drug-development partnerships. The organization also describes work on survivorship, caregiving, clinical trials, equitable access to care, and quality of life.
Its 2025 grants include research awards to cancer centers, universities, and medical institutions. For example, Memorial Sloan Kettering Cancer Center, which received $2,513,800, describes its mission as cancer prevention, treatment, and cure through patient care, outreach, research, and education. Fred Hutchinson Cancer Research Center, which received $1,550,000, describes its work as research ranging from foundational biology to population-level health. St. Jude Children’s Research Hospital, which received $1,308,000, says its mission is to advance cures and prevention for pediatric catastrophic diseases through research and treatment.
Grantmaking
In filing year 2025, Blood Cancer United reported 67 grants totaling $47,747,287. Grants ranged from $37,500 to $5,197,687, with a median of $370,000. The largest listed awards included $5,197,687 to Dana-Farber Cancer Institute, $2,518,448 to the University of Texas MD Anderson Cancer Center, and $2,513,800 to Sloan Kettering Institute for Cancer Research. These awards were identified as research grants.
The organization’s website describes research programs supporting basic, translational, and clinical studies, as well as projects on quality of life and late effects. The Translational Research Program’s 2025–2026 application cycle is closed. The website also lists the Student Mentorship and Research Training Program and Career Development Program as closed. The Equity in Access Research Grants program is described as supporting evidence to inform healthcare policy and practice. The website says the Therapy Acceleration Program accepts partnering inquiries year-round; its process includes submitting an inquiry form and a non-confidential presentation, followed by review of strategy, opportunity, and potential for success.
Leadership & Key People
Leadership team and compensation from IRS filings
The 2025 filing lists Alessandra Tocco as chair, Freda Wang as vice chair, and Marla Persky as secretary/treasurer. Directors listed include Janice Gabrilove, Leroy Ball, Richard Bagger, Mark Barrenechea, Renzo Canetta, M. Casey Cunningham, and Sharon Castellino.
Blood Cancer United Inc is led by E. Anders Kolb, President & CEO on the 2025 filing; 14 of 37 officers listed in 2025 are compensated.
Officers on the 2025 filing
E. Anders Kolb
President & CEO
New on the 2025 filing
40 hrs/week
$880K (2025)
Alessandra Tocco
Chair
Bod Member → Chair, 2025
On filings since 2022
4 hrs/week
No compensation reported
Gordon Miller Jr.
Executive Vice President & Chief Finance Officer
Executive Vice President & Chief Financial Officer → Executive Vice President & Chief Financial Ofc, 2024
Executive Vice President & Chief Financial Ofc → Executive Vice President & Chief Finance Officer, 2025
On filings since 2019
40 hrs/week
$284K (2019) → $648K (2025)
Gwen Nichols
Executive Vice President & Chief Med Officer
Executive Vice President & Chief Medical Officer → Executive Vice President & Chief Medical Ofc, 2024
Executive Vice President & Chief Medical Ofc → Executive Vice President & Chief Med Officer, 2025
On filings since 2019
40 hrs/week
$482K (2019) → $736K (2025)
Lee M. Greenberger
Senior Vice President & Chief Sci Officer -
Senior Vice President & Chief Scientific Officer → Senior Vice President & Chief Scientific Ofc, 2024
Senior Vice President & Chief Scientific Ofc → Senior Vice President & Chief Sci Officer -, 2025
On filings since 2019
40 hrs/week
$345K (2019) → $409K (2025)
Dale Nissenbaum
Former Executive Vice President & General Cnsl -
Executive Vice President General Counsel → Executive Vice President & General Counsel, 2023
Executive Vice President & General Counsel → Former Executive Vice President & General Cnsl -, 2025
On filings since 2022
40 hrs/week
$493K (2022) → $548K (2025)
Troy Dunmire
Former Executive Vice President & Cf Op Officer -
Executive Vice President & Chief Operating Officer → Executive Vice President & Chief Operating Ofc, 2024
Executive Vice President & Chief Operating Ofc → Former Executive Vice President & Cf Op Officer -, 2025
On filings since 2022
40 hrs/week
$593K (2022) → $263K (2025)
Florence Godfrey
Senior Vice President & Chief Experience Officer
Senior Vice President & Chief Experience Officer → Senior Vice President & Chief Experience Ofc, 2024
Senior Vice President & Chief Experience Ofc → Senior Vice President & Chief Experience Officer, 2025
On filings since 2023
40 hrs/week
$382K (2023) → $406K (2025)
Susan Brown
Senior Vice President & Chief Sus Officer
Senior Vice President & Chief Dei Officer → Senior Vice President & Chief Dei Ofc, 2024
Senior Vice President & Chief Dei Ofc → Senior Vice President & Chief Sus Officer, 2025
On filings since 2023
40 hrs/week
$426K (2023) → $422K (2025)
Andrew Perry
Senior Vice President, Bus Ops & Technology
New on the 2025 filing
40 hrs/week
$392K (2025)
Elisa Weiss
Senior Vice President & Education
New on the 2025 filing
40 hrs/week
$368K (2025)
Flora Coker Powell
Executive Vice President & Chief Rev Officer
New on the 2025 filing
40 hrs/week
$513K (2025)
Meredith Fogel
Executive Vice President & General Counsel - Start
New on the 2025 filing
40 hrs/week
$312K (2025)
Orlando Ashworth
Executive Vice President & Chief People - Start
New on the 2025 filing
40 hrs/week
$95K (2025)
Shonette Harrison Carew
Executive Vice President & Chief Administrator Officer - Start
New on the 2025 filing
40 hrs/week
$162K (2025)
Janice Gabrilove MD
At Large
Bod Member → At Large, 2024
On filings since 2019
4 hrs/week
No compensation reported
Jeff Sachs
Bod Member
Vice Chair → Chair, 2022
Chair → Bod Member, 2025
On filings since 2019
4 hrs/week
No compensation reported
Kathleen Meriwether
Bod Member
Secretary → Vice Chair, 2022
Vice Chair → Bod Member, 2025
On filings since 2019
4 hrs/week
No compensation reported
Lynne O'Brien
Bod Member
On filings since 2019
4 hrs/week
No compensation reported
Marla Persky
Secretary & Treasurer
Bod Member → Secretary & Treasurer, 2025
On filings since 2019
4 hrs/week
No compensation reported
Renzo Canetta
Bod Member
On filings since 2019
4 hrs/week
No compensation reported
Robert Rosen
Bod Member
On filings since 2019
4 hrs/week
No compensation reported
Ruben Mesa
Bod Member
On filings since 2019
4 hrs/week
No compensation reported
Freda Wang
Vice Chair
Secretary → Secretary & Treasurer, 2023
Secretary & Treasurer → Vice Chair, 2025
On filings since 2022
4 hrs/week
No compensation reported
Richard Bagger
Bod Member
On filings since 2022
4 hrs/week
No compensation reported
Richard Rendina
Bod Member
On filings since 2022
4 hrs/week
No compensation reported
Jim Reddoch
Bod Member
On filings since 2023
4 hrs/week
No compensation reported
Ari Melnick
Bod Member
On filings since 2024
4 hrs/week
No compensation reported
Leroy Ball
Bod Member
On filings since 2024
4 hrs/week
No compensation reported
Yvette Tremonti
Bod Member
On filings since 2024
4 hrs/week
No compensation reported
Alex Okafor
Bod Member
New on the 2025 filing
4 hrs/week
No compensation reported
Lilian Stern
Bod Member
New on the 2025 filing
4 hrs/week
No compensation reported
M. Casey Cunningham
Bod Member
New on the 2025 filing
4 hrs/week
No compensation reported
Mark Barrenechea
Bod Member
New on the 2025 filing
4 hrs/week
No compensation reported
Mike Farmer
Bod Member
New on the 2025 filing
4 hrs/week
No compensation reported
Rayne H. Rouce MD
Bod Member
New on the 2025 filing
4 hrs/week
No compensation reported
Sharon Castellino
Bod Member
New on the 2025 filing
4 hrs/week
No compensation reported
Former officers (46)
- Former: Bart Sichel (2019–2024) — Bod Member
- Former: Casey Cunningham MD (2019–2024) — Bod Member
- Former: Louis Jdegennaro (2019–2024) — President & CEO - Former · Filing note: Ended 63023
- Former: Coker Powell (2020–2024) — Senior Vice President & Chief Development Ofc
- Former: Vanessa White (2020–2024) — Senior Vice President & Chief Advancement Ofc
- Former: E. Anders Kolb - Start (2023–2024) — President & CEO
- Former: Helen Heslop (2024) — Bod Member
- Former: Mark Baeeenechea (2024) — Bod Member
- Former: Francine Heller (2019–2023) — Bod Member
- Former: John Greene (2019–2023) — Bod Member
- Former: Michele Cameron (2021–2023) — Bod Member · Filing note: Ended 121522
- Former: Ruben Mesa Md Facp (2021–2023) — At Large
- Former: Christopher Flowers (2019–2022) — Bod Member
- Former: Ralph E. Lawson (2019–2022) — Bod Member
- Former: Tom Osgood (2022) — Executive Vice President Chief Hr
- Former: Kathy Griesenbeck (2019–2021) — Executive Vice President Chief Re · Filing note: Ended 7312020
- Former: Rosemarie Aloffredo (2019–2021) — Chief Finance of · Filing note: Ended 3312019
- Former: Alessandra Tocco - Start (2021) — Bod Member
- Former: Freda Wang - Start (2021) — Bod Member
- Former: Margo Lucero (2021) — Executive Vice President Corp Par · Filing note: Ended 7312020
- Former: Ralph E. Lawson Fhfma CPA (2021) — Chairman
- Former: Rich Bagger - Start (2021) — Bod Member
- Former: Richard Rendina - Start (2021) — Bod Member
- Former: Troy Dunmire - Start (2021) — Executive Vice President Chief Op
- Former: A. Dana Callow Jr. (2019–2020) — Bod Member
- Former: Bernard H. Garil (2019–2020) — Bod Member
- Former: Harry Moseley (2019–2020) — Bod Member · Filing note: Ended 1152020
- Former: Jorge L. Benitez (2019–2020) — Chairman
- Former: Keith S. White (2019–2020) — Bod Member · Filing note: Ended 9302019
- Former: Michelle Le Beau PhD (2019–2020) — Bod Member
- Former: Peter B. Brock (2019–2020) — Bod Member
- Former: Robert Beck (2019–2020) — Executive Vice President Chief Op · Filing note: Ended 7519
- Former: Samuel Eberts (2019–2020) — Bod Member · Filing note: Ended 872019
- Former: Steven T. Rosen (2019–2020) — Bod Member
- Former: Thomas Osgood (2019–2020) — Executive Vice President Chief Hu
- Former: William G. Behnke (2019–2020) — Bod Member
- Former: James Palmer - Start (2020) — Bod Member
- Former: Michele Cameron - Start (2020) — Bod Member
- Former: Alice O'Rourke (2019) — Executive Vice President Chief De · Filing note: Ended 81518
- Former: Andrew S. Coccari (2019) — Executive Vice President Chief Pr · Filing note: Ended 7618
- Former: Connie Lindsey (2019) — Bod Member · Filing note: Ended 7312018
- Former: Donald Proctor (2019) — Bod Member
- Former: Kenneth M. Schwartz (2019) — Bod Member
- Former: Marcie Klein (2019) — Executive Vice President Communications
- Former: Ted Moroz (2019) — Bod Member
- Former: William Dalton (2019) — Bod Member · Filing note: Ended 10/31/2018
Data from IRS Form 990 filings, 2019–2025. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.
Compensation Overview
From 2025 IRS filing
The highest reported compensation on the 2025 filing was $880K, to E Anders Kolb (President & CEO). 14 officers or directors reported compensation on that filing.
Frequently asked questions about Blood Cancer United Inc
How much does Blood Cancer United Inc give each year?
Blood Cancer United Inc gave $47.7M across 67 grants in 2025, according to its 2025 IRS Form 990. In 2024 it gave $52.3M across 69 grants.
What is Blood Cancer United Inc's typical grant size?
Blood Cancer United Inc's median grant in 2025 was $370,000, and its average grant was $712,646, across 67 grants on its 2025 IRS Form 990. Organizations receiving their first grant from Blood Cancer United Inc that year got $461K on average.
Where does Blood Cancer United Inc give grants?
Blood Cancer United Inc's top state is Massachusetts, with 17% of the grant dollars itemized on its 2025 IRS Form 990. The next largest states were New York (16%) and California (9%). The most frequent recipient cities were Boston, MA (5 grants), New York, NY (5 grants), Philadelphia, PA (5 grants) and Atlanta, GA (3 grants).
Does Blood Cancer United Inc give general operating support?
Not in 2025: none of the 67 grants with a stated purpose on Blood Cancer United Inc's 2025 IRS Form 990 were described as general or operating support. Recurring purposes include "Research Grant" (65 grants).
Who are Blood Cancer United Inc's largest grantees?
Blood Cancer United Inc's largest 2025 grantees include Dana-Farber Cancer Institute Inc ($5,197,687), The University of Texas MD Anderson Cancer Center ($2,518,448) and Sloan Kettering Institute for Cancer Research ($2,513,800), according to its 2025 IRS Form 990. Together they received 21% of its itemized 2025 grant dollars.
How large is Blood Cancer United Inc?
Blood Cancer United Inc reported $532.2M in total assets on its 2025 IRS Form 990. Its revenue that year was $358.7M.
What does Blood Cancer United Inc fund?
The organization’s mission is to cure blood cancer and improve the quality of life of patients and their families. Its research funding spans discovery science, translational and clinical research, and drug-development partnerships. See mission & focus areas ↑
How do I apply for a grant from Blood Cancer United Inc?
Blood Cancer United Inc has no public application process in the sources Grantable reviewed. Check bloodcancerunited.org for current guidelines, or contact the foundation directly before submitting a request.
What is Blood Cancer United Inc's EIN?
Blood Cancer United Inc's EIN (Employer Identification Number) is 13-5644916. IRS Form 990 filing data is available on this page for 2019–2025.
Data last updated October 2026. Sourced from IRS Form 990 filings. Research dossier generated October 2026.
Data update history
(8)
When this profile's IRS filing data changed on Grantable
- Updated Form 990 for fiscal year 2023 (received by the IRS February 23, 2024)
- Updated Form 990 for fiscal year 2024 (received by the IRS February 12, 2025)
- Updated Form 990 for fiscal year 2025 (received by the IRS February 27, 2026)
- Updated Form 990 for fiscal year 2019 (received by the IRS February 4, 2020)
- Updated Form 990 for fiscal year 2020 (received by the IRS February 4, 2021)
- Updated Form 990 for fiscal year 2021 (received by the IRS February 7, 2022)
- Updated Form 990 for fiscal year 2022 (received by the IRS February 3, 2023)
- IRS filings on file for fiscal years 2019–2025
Explore Open Grants
Browse active grant opportunities in Blood Cancer United Inc's focus areas in our free grants database
Similar Funders
Funders that support many of the same organizations
American Cancer Society Inc
Atlanta, GA
The American Cancer Society funds cancer research, patient support, and advocacy, including grants to researchers, institutions, and related organizations. Its 2025 grants ranged from $5,648 to $9.6 million, with a median of $15,000; research funding supports institutions across the United States. It accepts applications for specific research programs through ProposalCentral, but the profile does not state whether it accepts unsolicited requests generally.
Assets
$1.7B
Grants
509
Total Given
$23.1M
Mayo Clinic
Rochester, MN
Mayo Clinic’s community grants support 501(c)(3) nonprofits addressing locally identified health needs and community well-being, such as access to care, mental health, and food security. Community grant amounts vary; its 2024 grants had a median of $59,957, though many much larger awards went to Mayo-affiliated organizations. Its community programs serve areas near Mayo sites, including Rochester, Florida, Arizona, and Mayo Clinic Health System communities; application information is stated for Rochester and Florida, but whether unsolicited requests are accepted is not stated.
Assets
$26.7B
Grants
256
Total Given
$572.1M
Yale University
New Haven, CT
Yale University funds sponsored research, education and institutional programs, student aid, and charitable or community support, with 2025 grants ranging from $3,000 to $14.3 million and a median of about $136,000. Grants went to recipients in multiple states, with the largest shares in Connecticut, California, Massachusetts, New York, and Pennsylvania. The information does not state whether Yale accepts unsolicited requests.
Assets
$58.9B
Grants
364
Total Given
$168.2M
American Heart Association Inc
Dallas, TX
The American Heart Association funds basic, clinical, behavioral, translational and population research on cardiovascular, cerebrovascular and brain health, along with research training and education programs. In 2025 it awarded 833 grants totaling about $198 million; amounts ranged from $5,000 to nearly $9.93 million, with a median of $20,000. Research awards are for eligible U.S.-based nonprofit institutions, and the profile describes a formal proposal process but does not state whether unsolicited requests are accepted.
Assets
$2.0B
Grants
833
Total Given
$198.2M
Emory University
Atlanta, GA
Emory University primarily funds research and subcontract work for universities, hospitals, research organizations, and other organizations, across a range of academic and health-related fields. Its 2025 grants ranged from $5,500 to $19.1 million, with a median of about $97,000; 41% of grant dollars went to Georgia recipients. The profile does not state whether Emory accepts unsolicited requests.
Assets
$24.9B
Grants
362
Total Given
$183.7M
Vanderbilt University Medical Center
Nashville, TN
Vanderbilt University Medical Center supports medical and scientific research, health and educational programs, and related institutional purposes, with grants to universities, medical centers, and research organizations. Its 2025 grants had a median of about $116,000, though awards ranged widely; recipients were based across the U.S., with the most funding going to Tennessee. The profile does not state whether it accepts unsolicited requests.
Assets
$7.8B
Grants
246
Total Given
$125.1M
More similar funders
More Funders in District of Columbia
Cite this profile
Grantable. (2026). Blood Cancer United Inc funder profile. GrantGraph. Retrieved October 15, 2026, from https://grantable.co/funders/blood-cancer-united-inc-morg_b76b29ab51914d5c893d46d1966da1c6
BibTeX
@misc{grantable_135644916_2026,
author = {{Grantable}},
title = {{Blood Cancer United Inc funder profile}},
howpublished = {GrantGraph},
year = {2026},
url = {https://grantable.co/funders/blood-cancer-united-inc-morg_b76b29ab51914d5c893d46d1966da1c6},
note = {Accessed 2026-10-15. Data licensed CC BY 4.0}
}The figures on this page are open data under CC BY 4.0: reuse them with credit to Grantable and a link. Download the data.
Figures come from Blood Cancer United Inc's IRS filings (methodology). AI-written summaries, news items and logos are not covered by the open licence. Spot an error? Email hello@grantable.co.
Blood Cancer United Inc down — hundreds of funders to go?